Neuroprotective peptide for cognitive function and mental clarity.
Compound_Description
Semax is a synthetic heptapeptide derived from adrenocorticotropic hormone (ACTH 4-10). Developed in Russia, Semax has been extensively studied for its nootropic and neuroprotective properties. Unlike ACTH, Semax lacks hormonal activity while retaining beneficial effects on the central nervous system.
The peptide works through multiple mechanisms, including modulation of brain-derived neurotrophic factor (BDNF), enhancement of cerebral blood flow, and protection against oxidative stress. Research suggests that Semax can influence neurotransmitter systems, particularly dopamine and serotonin pathways.
Studies have demonstrated Semax's potential in supporting cognitive function, memory formation, and learning capacity. The peptide has shown particular promise in research related to neuroprotection, with studies examining its effects on ischemic brain injury and neurodegenerative conditions.
Semax is administered intranasally, allowing for direct delivery to the central nervous system. This route of administration provides rapid onset of effects and bypasses the blood-brain barrier.
Research_Applications
- check_circle Cognitive function research
- check_circle Neuroprotection studies
- check_circle BDNF modulation research
- check_circle Cerebral blood flow studies
- check_circle Nootropic applications
Scientific_Studies
Semax Neuroprotective Effects
Ashmarin IP et al. demonstrated Semax's neuroprotective properties in various experimental models.
BDNF Modulation by Semax
Research showing Semax's ability to increase BDNF levels in the hippocampus.
Semax in Cognitive Enhancement
Clinical studies on Semax's effects on cognitive function and memory.
Research Use Only
This product is for laboratory research purposes only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.